Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Liver Diseases

  Free Subscription

Articles published in Biochem Biophys Res Commun

Retrieve available abstracts of 229 articles:
HTML format

Single Articles

    June 2024
  1. ZHANG S, Gao YF, Zhang K, Deng GR, et al
    Integrating network pharmacology and experimental validation reveals therapeutic effects of D-mannose on NAFLD through mTOR suppression.
    Biochem Biophys Res Commun. 2024;715:149999.
    PubMed     Abstract available

  2. YAMAMOTO T, Iizuka Y, Izumi-Yamamoto K, Shirota M, et al
    Overexpression of Slc22a18 facilitates fat accumulation in mice.
    Biochem Biophys Res Commun. 2024;712-713:149922.
    PubMed     Abstract available

  3. KIM DH, Kwon EJ, Park KG, Jin J, et al
    Acesulfame potassium upregulates PD-L1 in HCC cells by attenuating autophagic degradation.
    Biochem Biophys Res Commun. 2024;711:149921.
    PubMed     Abstract available

    May 2024
  4. MAO T, Zhang C, Yang S, Bi Y, et al
    Semaglutide alters gut microbiota and improves NAFLD in db/db mice.
    Biochem Biophys Res Commun. 2024;710:149882.
    PubMed     Abstract available

  5. LIU X, Liu R, Wang Y
    Indole-3-carboxaldehyde alleviates acetaminophen-induced liver injury via inhibition of oxidative stress and apoptosis.
    Biochem Biophys Res Commun. 2024;710:149880.
    PubMed     Abstract available

  6. DONG M, Zhang T, Liang X, Cheng X, et al
    Sesamin alleviates lipid accumulation induced by oleic acid via PINK1/Parkin-mediated mitophagy in HepG2 cells.
    Biochem Biophys Res Commun. 2024;708:149815.
    PubMed     Abstract available

  7. ZHENG E, Chen Q, Xiao A, Luo X, et al
    Systemic loss of CD36 aggravates NAFLD-related HCC through MEK1/2-ERK1/2 signaling pathway.
    Biochem Biophys Res Commun. 2024;707:149781.
    PubMed     Abstract available

    April 2024
  8. HE L, Peng L, Wang L, Jiang X, et al
    Investigation of folate-modified EGCG-loaded thermosensitive nanospheres inducing immunogenic cell death and damage-associated molecular patterns in hepatocellular carcinoma.
    Biochem Biophys Res Commun. 2024;714:149976.
    PubMed     Abstract available

  9. PENG J, Liang G, Li Y, Mao S, et al
    Identification of a novel FOXO3 agonist that protects against alcohol induced liver injury.
    Biochem Biophys Res Commun. 2024;704:149690.
    PubMed     Abstract available

  10. CAO Y, Wang S, Zhang M, Lai B, et al
    PFKFB3-mediated glycolysis in hepatic stellate cells promotes liver regeneration.
    Biochem Biophys Res Commun. 2024;712-713:149958.
    PubMed     Abstract available

  11. CHEN F
    Inhibiting Pink1/Parkin-mediated mitophagy enhances the anticancer effects of quercetin in hepatocellular carcinomaf.
    Biochem Biophys Res Commun. 2024;712-713:149899.
    PubMed     Abstract available

  12. WU M, Tie M, Hu L, Yang Y, et al
    Fatty liver disease protective MTARC1 p.A165T variant reduces the protein stability of MTARC1.
    Biochem Biophys Res Commun. 2024;702:149655.
    PubMed     Abstract available

    March 2024
  13. SEYAMA Y, Sudo K, Yamada T, Tsuchiya K, et al
    Ascorbic acid predominantly kills cancer stem cell-like cells in the hepatocellular carcinoma cell line Li-7 and is more effective at low cell density and in small spheroids.
    Biochem Biophys Res Commun. 2024;709:149816.
    PubMed     Abstract available

    February 2024
  14. SHANG S, Wan Q, Chen F, Hu J, et al
    Co-targeting ASK1 and THRbeta synergistically improves steatohepatitis and fibrosis in a MASH animal model.
    Biochem Biophys Res Commun. 2024;705:149739.
    PubMed     Abstract available

  15. HUANG W, Qian Y, Lin J, Wang F, et al
    Baicalein alleviates intrahepatic cholestasis by regulating bile acid metabolism via an FXR-dependent manner.
    Biochem Biophys Res Commun. 2024;705:149670.
    PubMed     Abstract available

  16. CHO W, Oh H, Abd El-Aty AM, Ozten O, et al
    Interleukin-27 as a novel player in alleviating hepatic steatosis: Mechanistic insights from an in vitro analysis.
    Biochem Biophys Res Commun. 2024;703:149671.
    PubMed     Abstract available

  17. KALISHWARALAL K, Azeez Nazeer A, Induja DK, Keerthana CK, et al
    Enhanced extracellular vesicles mediated uttroside B (Utt-B) delivery to Hepatocellular carcinoma cell: Pharmacokinetics based on PBPK modelling.
    Biochem Biophys Res Commun. 2024;703:149648.
    PubMed     Abstract available

  18. YUAN X, Wen Y, Shi Q, Zhao Y, et al
    MicroRNA-148a-3p suppresses the glycolysis and Cell proliferation by targeting transmembrane protein 54 in liver cancer.
    Biochem Biophys Res Commun. 2024;695:149424.
    PubMed     Abstract available

    January 2024
  19. ZHANG M, Shi X, Tang M, Yin W, et al
    PRDX2 deficiency increases MCD-induced nonalcoholic steatohepatitis in female mice.
    Biochem Biophys Res Commun. 2024;701:149589.
    PubMed     Abstract available

  20. LI C, Liang G, Yan K, Wang Y, et al
    NRF2 mutation enhances the immune escape of hepatocellular carcinoma by reducing STING activation.
    Biochem Biophys Res Commun. 2024;698:149536.
    PubMed     Abstract available

  21. JIN M, Mi Y, Li F, Ren F, et al
    ZNF131 facilitates the growth of hepatocellular carcinoma by acting as a transcriptional activator of SMC4 expression.
    Biochem Biophys Res Commun. 2024;696:149515.
    PubMed     Abstract available

  22. LEE S, Memon A, Chae SC, Shin D, et al
    Epcam regulates intrahepatic bile duct reconstruction in zebrafish, providing a potential model for primary cholangitis model.
    Biochem Biophys Res Commun. 2024;696:149512.
    PubMed     Abstract available

  23. BAE S, Moon YA
    Deletion of Elovl5 leads to dyslipidemia and atherosclerosis in LDLR-deficient mice.
    Biochem Biophys Res Commun. 2024;690:149292.
    PubMed     Abstract available

    December 2023
  24. ABI ZAMER B, Rah B, Jayakumar MN, Abumustafa W, et al
    DNA methylation-mediated epigenetic regulation of oncogenic RPS2 as a novel therapeutic target and biomarker in hepatocellular carcinoma.
    Biochem Biophys Res Commun. 2023;696:149453.
    PubMed     Abstract available

  25. ABDELRAHMAN BA, Hammam OA, El-Khatib AS, Attia YM, et al
    The role of vitamin D3 in modulating the interplay between NLRP3 inflammasome and autophagy in NASH.
    Biochem Biophys Res Commun. 2023;688:149122.
    PubMed     Abstract available

  26. ZHAO H, Han G, Jiang Z, Gao D, et al
    Identification of BMAL1-Regulated circadian genes in mouse liver and their potential association with hepatocellular carcinoma: Gys2 and Upp2 as promising candidates.
    Biochem Biophys Res Commun. 2023;696:149422.
    PubMed     Abstract available

  27. HORIKOSHI M, Harada K, Tsuno S, Kitaguchi T, et al
    Distinct lactate metabolism between hepatocytes and myotubes revealed by live cell imaging with genetically encoded indicators.
    Biochem Biophys Res Commun. 2023;694:149416.
    PubMed     Abstract available

  28. NAMBA N, Kuwahara T, Kondo Y, Fukusaki K, et al
    Fasudil inhibits the expression of C/EBP homologous protein to protect against liver injury in acetaminophen-overdosed mice.
    Biochem Biophys Res Commun. 2023;686:149166.
    PubMed     Abstract available

  29. CAO J, Zhong Q, Huang Y, Zhu M, et al
    Identification and validation of INHBE and P4HA1 as hub genes in non-alcoholic fatty liver disease.
    Biochem Biophys Res Commun. 2023;686:149180.
    PubMed     Abstract available

  30. IMAMORI M, Hosooka T, Imi Y, Hosokawa Y, et al
    Thrombospondin-1 promotes liver fibrosis by enhancing TGF-beta action in hepatic stellate cells.
    Biochem Biophys Res Commun. 2023;693:149369.
    PubMed     Abstract available

  31. QU D, Chen M, Zhu H, Liu X, et al
    Akkermansia muciniphila and its outer membrane protein Amuc_1100 prevent high-fat diet-induced nonalcoholic fatty liver disease in mice.
    Biochem Biophys Res Commun. 2023;684:149131.
    PubMed     Abstract available

    November 2023
  32. HE J, Han J, Lin K, Wang J, et al
    PTEN/AKT and Wnt/beta-catenin signaling pathways regulate the proliferation of Lgr5+ cells in liver cancer.
    Biochem Biophys Res Commun. 2023;683:149117.
    PubMed     Abstract available

  33. FENG R, Cheng D, Chen X, Yang L, et al
    Identification and validation of palmitoylation metabolism-related signature for liver hepatocellular carcinoma.
    Biochem Biophys Res Commun. 2023;692:149325.
    PubMed     Abstract available

  34. HAN Q, Yan X, Wang L, Zhang N, et al
    Aryl hydrocarbon receptor attenuates cholestatic liver injury by regulating bile acid metabolism.
    Biochem Biophys Res Commun. 2023;682:259-265.
    PubMed     Abstract available

  35. SUO L, Gao M, Ma T, Gao Z, et al
    Effect of RPL27 knockdown on the proliferation and apoptosis of human liver cancer cells.
    Biochem Biophys Res Commun. 2023;682:156-162.
    PubMed     Abstract available

  36. LIN X, Pan F, Abudoureyimu M, Wang T, et al
    Aurora-A inhibitor synergistically enhances the inhibitory effect of anlotinib on hepatocellular carcinoma.
    Biochem Biophys Res Commun. 2023;690:149247.
    PubMed     Abstract available

  37. RAMPOGU S, Badvel P, Hoon Jo B, Kim Y, et al
    A review on Millepachine and its derivatives as potential multitarget anticancer agents.
    Biochem Biophys Res Commun. 2023;681:249-270.
    PubMed     Abstract available

  38. WANG S, Yi W, Xu Z, Shi M, et al
    PYCR2 promotes growth and aerobic glycolysis in human liver cancer by regulating the AKT signaling pathway.
    Biochem Biophys Res Commun. 2023;680:15-24.
    PubMed     Abstract available

    October 2023
  39. CHEN X, Wang D, Wang Z, Huang W, et al
    Identification of pyroptosis-related genes in NASH based on bioinformatic analysis.
    Biochem Biophys Res Commun. 2023;679:90-97.
    PubMed     Abstract available

  40. ZHONG F, Wang Y
    YY1-regulated lncRNA SOCS2-AS1 suppresses HCC cell stemness and progression via miR-454-3p/CPEB1.
    Biochem Biophys Res Commun. 2023;679:98-109.
    PubMed     Abstract available

  41. JUNG M, Ji E, Kang H, Kim C, et al
    The microRNA-195-5p/hnRNP A1 axis contributes to the progression of hepatocellular carcinoma by regulating the migration of cancer cells.
    Biochem Biophys Res Commun. 2023;686:149183.
    PubMed     Abstract available

  42. JIN Q, Hu Y, Gao Y, Zheng J, et al
    Hhex and Prox1a synergistically dictate the hepatoblast to hepatocyte differentiation in zebrafish.
    Biochem Biophys Res Commun. 2023;686:149182.
    PubMed     Abstract available

  43. DARIJANI MH, Aminzadeh A, Rahimi HR, Mandegary A, et al
    Evaluating the protective effect of metformin against diclofenac-induced oxidative stress and hepatic damage: In vitro and in vivo studies.
    Biochem Biophys Res Commun. 2023;685:149168.
    PubMed     Abstract available

  44. SU H, Shu S, Tang W, Zheng C, et al
    ETV4 facilitates angiogenesis in hepatocellular carcinoma by upregulating MMP14 expression.
    Biochem Biophys Res Commun. 2023;684:149137.
    PubMed     Abstract available

  45. GHEYBI F, Khooei A, Hoseinian A, Doagooyan M, et al
    Alleviation of acetaminophen-induced liver failure using silibinin nanoliposomes: An in vivo study.
    Biochem Biophys Res Commun. 2023;676:103-108.
    PubMed     Abstract available

  46. JOUENNE A, Hamici K, Varlet I, Sourdon J, et al
    Relationship of cardiac remodeling and perfusion alteration with hepatic lipid metabolism in a prediabetic high fat high sucrose diet female rat model.
    Biochem Biophys Res Commun. 2023;682:207-215.
    PubMed     Abstract available

  47. KIM J, Choi A, Kwon YH
    Maternal low-protein diet alters hepatic lipid accumulation and gene expression related to glucose metabolism in young adult mouse offspring fed a postweaning high-fat diet.
    Biochem Biophys Res Commun. 2023;682:193-198.
    PubMed     Abstract available

  48. SUN G, Wei Y, Zhu J, Zheng S, et al
    The transcription factor T-bet promotes the pathogenesis of nonalcoholic fatty liver disease by upregulating intrahepatic inflammation.
    Biochem Biophys Res Commun. 2023;682:266-273.
    PubMed     Abstract available

  49. HANAKI Y, Shikata Y, Kikumori M, Okamura M, et al
    Invivo anti-cancer activity of 10-methyl-aplog-1, a simplified analog of aplysiatoxin, and its possible signaling pathway associated with G1 arrest.
    Biochem Biophys Res Commun. 2023;675:19-25.
    PubMed     Abstract available

    September 2023
  50. ZHENG D, Bashir M, Li Z
    ERalpha prevents tumorigenesis of both liver and breast cancer cells through CCN5.
    Biochem Biophys Res Commun. 2023;672:103-112.
    PubMed     Abstract available

  51. HAN YH, He XM, Jin MH, Sun HN, et al
    Lipophagy: A potential therapeutic target for nonalcoholic and alcoholic fatty liver disease.
    Biochem Biophys Res Commun. 2023;672:36-44.
    PubMed     Abstract available

  52. ABRAHAMS Y, Willmer T, Patel O, Samodien E, et al
    A high fat, high sugar diet induces hepatic Peroxisome proliferator-activated receptor gamma coactivator 1-alpha promoter hypermethylation in male Wistar rats.
    Biochem Biophys Res Commun. 2023;680:25-33.
    PubMed     Abstract available

    August 2023
  53. NIAN F, Zhu C, Jin N, Xia Q, et al
    Gut microbiota metabolite TMAO promoted lipid deposition and fibrosis process via KRT17 in fatty liver cells in vitro.
    Biochem Biophys Res Commun. 2023;669:134-142.
    PubMed     Abstract available

  54. KE X, Hu H, Peng Q, Ying H, et al
    USP33 promotes nonalcoholic fatty acid disease-associated fibrosis in gerbils via the c-myc signaling.
    Biochem Biophys Res Commun. 2023;669:68-76.
    PubMed     Abstract available

  55. WANG H, Liu Y, Cui J, Tong M, et al
    Effects of Scutellaria strigillosa Hemsl. extract on HepG2 cell proliferation and apoptosis through binding to aspartate beta-hydroxylase.
    Biochem Biophys Res Commun. 2023;668:62-69.
    PubMed     Abstract available

    July 2023
  56. CHEN J, Hao Y, Xu P, Bian D, et al
    CerS5 deficiency promotes liver fibrosis development in non-alcoholic fatty liver disease.
    Biochem Biophys Res Commun. 2023;667:120-126.
    PubMed     Abstract available

  57. WANG Z, Huang Y, Zhu M, Cao J, et al
    TLR2 and CASP7 as the biomarkers associated with non-alcoholic fatty liver disease and chronic kidney disease.
    Biochem Biophys Res Commun. 2023;667:50-57.
    PubMed     Abstract available

  58. AKI T, Tanaka H, Funakoshi T, Unuma K, et al
    Excessive N-acetylcysteine exaggerates glutathione redox homeostasis and apoptosis during acetaminophen exposure in Huh-7 human hepatoma cells.
    Biochem Biophys Res Commun. 2023;676:66-72.
    PubMed     Abstract available

    June 2023
  59. LAN T, Wang W, Zeng XX, Tong YH, et al
    Saikosaponin A triggers cell ferroptosis in hepatocellular carcinoma by inducing endoplasmic reticulum stress-stimulated ATF3 expression.
    Biochem Biophys Res Commun. 2023;674:10-18.
    PubMed     Abstract available

  60. DU D, Wang S, Li T, Liu Z, et al
    RHNO1 disruption inhibits cell proliferation and induces mitochondrial apoptosis via PI3K/Akt pathway in hepatocellular carcinoma.
    Biochem Biophys Res Commun. 2023;673:96-105.
    PubMed     Abstract available

    May 2023
  61. JI S, Xu M, Cai C, He X, et al
    MESP1-knockdown inhibits the proliferation and epithelial mesenchymal transition of hepatocellular carcinoma and enhances the tumor-suppressive effect of 5-fluorouracil.
    Biochem Biophys Res Commun. 2023;670:1-11.
    PubMed     Abstract available

  62. AKL MG, Baccetto R, Stebbings BM, Li L, et al
    Euglycemia is affected by stress defense factor hepatocyte NRF1, but not NRF2.
    Biochem Biophys Res Commun. 2023;668:96-103.
    PubMed     Abstract available

  63. KHALIFA MO, Moriwaki T, Zhang S, Zhou W, et al
    Negative pressure induces dedifferentiation of hepatocytes via RhoA/ROCK pathway.
    Biochem Biophys Res Commun. 2023;667:104-110.
    PubMed     Abstract available

    April 2023
  64. UEHARA S, Higuchi Y, Yoneda N, Ito R, et al
    HepaSH cells: Experimental human hepatocytes with lesser inter-individual variation and more sustainable availability than primary human hepatocytes.
    Biochem Biophys Res Commun. 2023;663:132-141.
    PubMed     Abstract available

  65. LIN Y, Fang H, Ma C, Zhou J, et al
    ACLY-beta-catenin axis modulates hepatoblastoma cell proliferation.
    Biochem Biophys Res Commun. 2023;663:104-112.
    PubMed     Abstract available

  66. ZENG S, Tao M, Yuan L, Zhang L, et al
    Inhibition of mGluR5 ameliorates lipid accumulation and inflammation in HepG2 cells.
    Biochem Biophys Res Commun. 2023;653:1-11.
    PubMed     Abstract available

  67. CHEN L, Li Z, Wei W, An B, et al
    Human embryonic stem cell-derived immunity-and-matrix regulatory cells promote intrahepatic cell renewal to rescue acute liver failure.
    Biochem Biophys Res Commun. 2023;662:104-113.
    PubMed     Abstract available

  68. BI S, Zhang Y, Zhou J, Yao Y, et al
    miR-210 promotes hepatocellular carcinoma progression by modulating macrophage autophagy through PI3K/AKT/mTOR signaling.
    Biochem Biophys Res Commun. 2023;662:47-57.
    PubMed     Abstract available

  69. LI L, Xiong Y, Cao W, Chen Z, et al
    Epidermal growth factor receptor promotes high-fructose nonalcoholic fatty liver disease by inducing mitochondrial fission in zebrafish.
    Biochem Biophys Res Commun. 2023;652:112-120.
    PubMed     Abstract available

  70. WANG Q, Peng X, Chen Y, Tang X, et al
    Piezo1 alleviates acetaminophen-induced acute liver injury by activating Nrf2 and reducing mitochondrial reactive oxygen species.
    Biochem Biophys Res Commun. 2023;652:88-94.
    PubMed     Abstract available

  71. ZHANG N, Guo F, Song Y
    HOXC8/TGF-beta1 positive feedback loop promotes liver fibrosis and hepatic stellate cell activation via activating Smad2/Smad3 signaling.
    Biochem Biophys Res Commun. 2023;662:39-46.
    PubMed     Abstract available

  72. KIM D, Choi I, Ha SK, Gonzalez FJ, et al
    Keratin 79 is a PPARA target that is highly expressed by liver damage.
    Biochem Biophys Res Commun. 2023;650:132-136.
    PubMed     Abstract available

  73. QIN Z, Wang P, Chen W, Wang JR, et al
    Hepatic ELOVL3 is dispensable for lipid metabolism in mice.
    Biochem Biophys Res Commun. 2023;658:128-135.
    PubMed     Abstract available

    March 2023
  74. CHO W, Choi SW, Oh H, Baygutalp F, et al
    Musclin attenuates lipid deposition in hepatocytes through SIRT7/autophagy-mediated suppression of ER stress.
    Biochem Biophys Res Commun. 2023;658:62-68.
    PubMed     Abstract available

  75. ZHU W, Dong X, Luo S, Guo S, et al
    Transcriptional activation of CSTB gene expression by transcription factor Sp3.
    Biochem Biophys Res Commun. 2023;649:71-78.
    PubMed     Abstract available

  76. ZHU C, Guo H, Ma Z, Shi S, et al
    FOXM1 augments sorafenib resistance and promotes progression of hepatocellular carcinoma by epigenetically activating KIF23 expression.
    Biochem Biophys Res Commun. 2023;656:1-9.
    PubMed     Abstract available

  77. GUO J, Duan H, Li Y, Yang L, et al
    Retraction notice to "A novel circular RNA circ-ZNF652 promotes hepatocellular carcinoma metastasis through inducing snail-mediated epithelial-mesenchymal transition by sponging miR-203/miR-502-5p" [YBBRC 513(4) (2019) 812-819].
    Biochem Biophys Res Commun. 2023 Mar 13:S0006-291X(23)00243.
    PubMed     Abstract available

  78. ANDO T, Ito D, Shiogama K, Sakai Y, et al
    Administration of spermidine attenuates concanavalin A-induced liver injury.
    Biochem Biophys Res Commun. 2023;648:44-49.
    PubMed     Abstract available

  79. NATU A, Pedgaonkar A, Gupta S
    Mitochondrial dysfunction and chromatin changes with autophagy-mediated survival in doxorubicin resistant cancer cell lines.
    Biochem Biophys Res Commun. 2023;648:1-10.
    PubMed     Abstract available

    February 2023
  80. YANG H, Wang Q, Zhang P, Cheng K, et al
    Preliminary mechanism of inhibitor of SGLT2 in fatty liver cold ischemia injury.
    Biochem Biophys Res Commun. 2023;646:96-102.
    PubMed     Abstract available

  81. ZENG R, Zeng Y, Wang Q, Li X, et al
    Sleeve gastrectomy decreased hepatic lipid accumulation by inducing autophagy via AMPK/mTOR pathway.
    Biochem Biophys Res Commun. 2023;653:115-125.
    PubMed     Abstract available

  82. LU Y, Wang M, Zhao M, Zhang Q, et al
    Filamin A is overexpressed in non-alcoholic steatohepatitis and contributes to the progression of inflammation and fibrosis.
    Biochem Biophys Res Commun. 2023;653:93-101.
    PubMed     Abstract available

  83. HE X, Chen F, Lu C, Wang S, et al
    Comparison of anti-tumor activities and underlying mechanisms of glucuronomannan oligosaccharides and its sulfated derivatives on the hepatocarcinoma Huh7.5 cells.
    Biochem Biophys Res Commun. 2023;652:103-111.
    PubMed     Abstract available

  84. KOU K, Li S, Qiu W, Fan Z, et al
    Hypoxia-inducible factor 1alpha/IL-6 axis in activated hepatic stellate cells aggravates liver fibrosis.
    Biochem Biophys Res Commun. 2023;653:21-30.
    PubMed     Abstract available

  85. HOU B, Qin L, Huang L
    Liver cancer cells as the model for developing liver-targeted RNAi therapeutics.
    Biochem Biophys Res Commun. 2023;644:85-94.
    PubMed     Abstract available

  86. AKI T, Kukita M, Takata M, Funakoshi T, et al
    Induction of and its involvement in the regulation of cellular senescence and apoptosis in Huh-7 hepatoma cells during exposure.
    Biochem Biophys Res Commun. 2023;651:92-97.
    PubMed     Abstract available

  87. NTAMBI JM, Liu X, Burhans MS, ALjohani A, et al
    Hepatic oleate regulates one-carbon metabolism during high carbohydrate feeding.
    Biochem Biophys Res Commun. 2023;651:62-69.
    PubMed     Abstract available

  88. ZHAO T, Han Z, Zhang J, Ding Y, et al
    Effect of ADHI on hepatic stellate cell activation and liver fibrosis in mice.
    Biochem Biophys Res Commun. 2023;651:98-106.
    PubMed     Abstract available

    January 2023
  89. CHO W, Choi SW, Oh H, Abd El-Aty AM, et al
    Oroxylin-A alleviates hepatic lipid accumulation and apoptosis under hyperlipidemic conditions via AMPK/FGF21 signaling.
    Biochem Biophys Res Commun. 2023;648:59-65.
    PubMed     Abstract available

  90. XUE G, Zhang J, Wu L, Sun S, et al
    Differentiation of umbilical cord mesenchymal stem cells into hepatocytes with CYP450 metabolic enzyme activity induced by a liver injury microenvironment.
    Biochem Biophys Res Commun. 2023;647:47-54.
    PubMed     Abstract available

  91. JIANG Z, Sun H, Miao J, Sheng Q, et al
    The natural flavone acacetin protects against high-fat diet-induced lipid accumulation in the liver via the endoplasmic reticulum stress/ferroptosis pathway.
    Biochem Biophys Res Commun. 2023;640:183-191.
    PubMed     Abstract available

  92. YOU K, Wang Y, Chen X, Yang Z, et al
    Neutralizing serum amyloid a protects against sinusoidal endothelial cell damage and platelet aggregation during acetaminophen-induced liver injury.
    Biochem Biophys Res Commun. 2023;639:20-28.
    PubMed     Abstract available

    December 2022
  93. LI Y, Yin Y, He Y, He K, et al
    SOS1 regulates HCC cell epithelial-mesenchymal transition via the PI3K/AKT/mTOR pathway.
    Biochem Biophys Res Commun. 2022;637:161-169.
    PubMed     Abstract available

  94. AGGARWAL S, Yadav V, Maiwall R, Rastogi A, et al
    Metabolomic analysis shows dysregulation in amino acid and NAD+ metabolism in palmitate treated hepatocytes and plasma of non-alcoholic fatty liver disease spectrum.
    Biochem Biophys Res Commun. 2022;643:129-138.
    PubMed     Abstract available

  95. ZHANG J, Yang Z, Yan X, Duan J, et al
    RNA-binding protein SPEN controls hepatocyte maturation via regulating Hnf4alpha expression during liver development.
    Biochem Biophys Res Commun. 2022;642:128-136.
    PubMed     Abstract available

  96. WU K, Zou J, Sack MN
    The endo-lysosomal regulatory protein BLOC1S1 modulates hepatic lysosomal content and lysosomal lipolysis.
    Biochem Biophys Res Commun. 2022;642:1-10.
    PubMed     Abstract available

  97. SUN X, Yu Q, Kang B, Zhao X, et al
    Diethyldithiocarbamate inhibits the activation of hepatic stellate cells via PPARalpha/FABP1 in mice with non-alcoholic steatohepatitis.
    Biochem Biophys Res Commun. 2022;641:192-199.
    PubMed     Abstract available

    The role of Stearoyl-CoA desaturase in hepatic de novo lipogenesis.
    Biochem Biophys Res Commun. 2022;633:81-83.
    PubMed     Abstract available

  99. IWANAGA T, Chiba T, Nakamura M, Kaneko T, et al
    Miglustat, a glucosylceramide synthase inhibitor, mitigates liver fibrosis through TGF-beta/Smad pathway suppression in hepatic stellate cells.
    Biochem Biophys Res Commun. 2022;642:192-200.
    PubMed     Abstract available

  100. CHEN W, Ru J, Wu T, Man D, et al
    MiR-652-3p promotes malignancy and metastasis of cancer cells via inhibiting TNRC6A in hepatocellular carcinoma.
    Biochem Biophys Res Commun. 2022;640:1-11.
    PubMed     Abstract available

  101. ZHANG F, Wu J, Ruan H, Xia J, et al
    ZeXie decoction alleviates non-alcoholic fatty liver disease in rats: the study of genes, lipids, and gut microbiotas.
    Biochem Biophys Res Commun. 2022;632:129-138.
    PubMed     Abstract available

  102. WU F, Tu C, Zhang K, Che H, et al
    Knockdown of PKMYT1 is associated with autophagy inhibition and apoptosis induction and suppresses tumor progression in hepatocellular carcinoma.
    Biochem Biophys Res Commun. 2022;640:173-182.
    PubMed     Abstract available

    November 2022
  103. LEI X, Hu X, Lu Q, Yao Y, et al
    UBE2K promotes the malignant progression of hepatocellular carcinoma by regulating c-Myc.
    Biochem Biophys Res Commun. 2022;638:210-218.
    PubMed     Abstract available

  104. ZHAO Q
    Mutant IDH1 attenuates hepatic lipogenesis through PTEN dependent pathway.
    Biochem Biophys Res Commun. 2022;637:254-258.
    PubMed     Abstract available

  105. KIM SQ, Mohallem R, Franco J, Buhman KK, et al
    Global landscape of protein complexes in postprandial-state livers from diet-induced obese and lean mice.
    Biochem Biophys Res Commun. 2022;629:40-46.
    PubMed     Abstract available

  106. DU X, Li H, Han X, Ma W, et al
    Mesenchymal stem cells-derived exosomal miR-24-3p ameliorates non-alcohol fatty liver disease by targeting Keap-1.
    Biochem Biophys Res Commun. 2022;637:331-340.
    PubMed     Abstract available

    October 2022
  107. WANG Q, Zheng K, Tan D, Liang G, et al
    TREM2 knockdown improves the therapeutic effect of PD-1 blockade in hepatocellular carcinoma.
    Biochem Biophys Res Commun. 2022;636.
    PubMed     Abstract available

  108. IQBAL T, Nawaz A, Karim M, Yaku K, et al
    Loss of hepatic Nmnat1 has no impact on diet-induced fatty liver disease.
    Biochem Biophys Res Commun. 2022;636.
    PubMed     Abstract available

  109. LEE KM, Hwang YJ, Jung GS
    Gemigliptin exerts protective effects against doxorubicin-induced hepatotoxicity by inhibiting apoptosis via the regulation of fibroblast growth factor 21 expression.
    Biochem Biophys Res Commun. 2022;626:135-141.
    PubMed     Abstract available

  110. TIAN-QI C, Yan-Fang D, Yan-Yan W, Yong-Hui Z, et al
    Butyrolactone I attenuates inflammation in murine NASH by inhibiting the NF-kappaB signaling pathway.
    Biochem Biophys Res Commun. 2022;626:167-174.
    PubMed     Abstract available

  111. LIN C, Yang H, Zhao W, Wang W, et al
    CTSB(+) macrophage repress memory immune hub in the liver metastasis site of colorectal cancer patient revealed by multi-omics analysis.
    Biochem Biophys Res Commun. 2022;626:8-14.
    PubMed     Abstract available

  112. OHKOSHI-YAMADA M, Kamimura K, Kimura A, Tanaka Y, et al
    Effects of a selective PPARalpha modulator, sodium-glucose cotransporter 2 inhibitor, and statin on the myocardial morphology of medaka nonalcoholic fatty liver disease model.
    Biochem Biophys Res Commun. 2022;625:116-121.
    PubMed     Abstract available

  113. TU H, Yin X, Wen J, Wu W, et al
    Glutaminase 1 blockade alleviates nonalcoholic steatohepatitis via promoting proline metabolism.
    Biochem Biophys Res Commun. 2022;634:1-9.
    PubMed     Abstract available

  114. HUANG Y, Liang W, Li K, Liao X, et al
    Sorafenib suppresses the activation of type I interferon pathway induced by RLR-MAVS and cGAS-STING signaling.
    Biochem Biophys Res Commun. 2022;623:181-188.
    PubMed     Abstract available

  115. CUI B, Yang L, Zhao Y, Lu X, et al
    HOXA13 promotes liver regeneration through regulation of BMP-7.
    Biochem Biophys Res Commun. 2022;623:23-31.
    PubMed     Abstract available

  116. SAMERI MJ, Savari F, Hoseinynejad K, Danyaei A, et al
    The hepato-protective effect of H2S-modified and non-modified mesenchymal stem cell exosomes on liver ischemia-reperfusion injury in mice: The role of MALAT1.
    Biochem Biophys Res Commun. 2022;635:194-202.
    PubMed     Abstract available

    September 2022
  117. ZHAO S, Liu X, Li L, Kong X, et al
    KIRA8 attenuates non-alcoholic steatohepatitis through inhibition of the IRE1alpha/XBP1 signalling pathway.
    Biochem Biophys Res Commun. 2022;632:158-164.
    PubMed     Abstract available

  118. ZHANG W, Xue H, Zhou C, Zheng Z, et al
    7-aminocephalosporanic acid, a novel HSP90beta inhibitor, attenuates HFD-induced hepatic steatosis.
    Biochem Biophys Res Commun. 2022;622:184-191.
    PubMed     Abstract available

  119. ZHONG F, Chen T, Li B
    Combinatorial transcriptional regulation of HEB/ZEB1/ASCL1 and MYBL2 on Ras/ErbB signaling.
    Biochem Biophys Res Commun. 2022;622:170-176.
    PubMed     Abstract available

  120. MAO X, Wu D, Xu N, Wang J, et al
    The danger signal interferon-induced protein 35 (IFP35) mediates acetaminophen-induced liver injury.
    Biochem Biophys Res Commun. 2022;621:25-31.
    PubMed     Abstract available

  121. SUN TT, Liu XL, Yang GY, Zhang W, et al
    Neurotrophic factors stimulate the activation of hepatic stellate cells in liver fibrosis.
    Biochem Biophys Res Commun. 2022;630:167-174.
    PubMed     Abstract available

  122. XU Y, Lu Y
    Alcoholic fatty liver is blunted by rFGF21 administration in mice lacking adipose FGFR1: The role of FGF21 in PPARalpha-mediated regulation of adipose tissue mass.
    Biochem Biophys Res Commun. 2022;619:84-89.
    PubMed     Abstract available

    August 2022
  123. CHU K, Zhao N, Hu X, Feng R, et al
    LncNONMMUG027912 alleviates lipid accumulation through AMPKalpha/mTOR/SREBP1C axis in nonalcoholic fatty liver.
    Biochem Biophys Res Commun. 2022;618:8-14.
    PubMed     Abstract available

  124. LEI X, Dai X, Wang Q, Long R, et al
    RNA-seq transcriptome profiling of liver regeneration in mice identifies the miR-34b-5p/phosphoinositide-dependent protein kinase 1 axis as a potential target for hepatocyte proliferation.
    Biochem Biophys Res Commun. 2022;627:111-121.
    PubMed     Abstract available

  125. LU Z, Yang H, Shao Y, Sun W, et al
    IGF2BP3-NRF2 axis regulates ferroptosis in hepatocellular carcinoma.
    Biochem Biophys Res Commun. 2022;627:103-110.
    PubMed     Abstract available

  126. JIA M, Xiao Y, Zhang C, Jiang T, et al
    Mitoxantrone alleviates hepatic steatosis induced by high-fat diet in broilers.
    Biochem Biophys Res Commun. 2022;627:52-59.
    PubMed     Abstract available

  127. PEI Y, Balogun O, Otieno D, Parks JS, et al
    The effects of brewers' spent grain on high-fat diet-induced fatty liver.
    Biochem Biophys Res Commun. 2022;616:49-55.
    PubMed     Abstract available

  128. CHEN Y, Zhang X
    TRABID targets DDB2 for deubiquitination to promote proliferation of hepatocellular carcinoma cells.
    Biochem Biophys Res Commun. 2022;625:23-30.
    PubMed     Abstract available

    July 2022
  129. LI L, Li S, Wang H, Li L, et al
    GSG2 promotes tumor growth through regulating cell proliferation in hepatocellular carcinoma.
    Biochem Biophys Res Commun. 2022;625:109-115.
    PubMed     Abstract available

  130. MORI J, Sawada T, Baba T, Hayakawa A, et al
    Identification of cell cycle-associated and -unassociated regulators for expression of a hepatocellular carcinoma oncogene cyclin-dependent kinase inhibitor 3.
    Biochem Biophys Res Commun. 2022;625:46-52.
    PubMed     Abstract available

  131. ZHOU J, Liu T, Xu H, Wang Y, et al
    LncRNA FIRRE promotes the proliferation and metastasis of hepatocellular carcinoma by regulating the expression of PXN through interacting with MBNL3.
    Biochem Biophys Res Commun. 2022;625:188-195.
    PubMed     Abstract available

  132. ZHANG X, Tao X, Feng F
    Downregulation of C12orf75 gene inhibits migration and invasion of liver cancer cell via suppressing the Wnt/beta-catenin signaling pathway in vitro.
    Biochem Biophys Res Commun. 2022;614:92-99.
    PubMed     Abstract available

  133. TANG C, Qiu S, Mou W, Xu J, et al
    Excessive activation of HOXB13/PIMREG axis promotes hepatocellular carcinoma progression and drug resistance.
    Biochem Biophys Res Commun. 2022;623:81-88.
    PubMed     Abstract available

  134. HU X, Pan H, Zhou S, Pang Q, et al
    HS1BP3, transcriptionally regulated by ESR1, promotes hepatocellular carcinoma progression.
    Biochem Biophys Res Commun. 2022;623:111-119.
    PubMed     Abstract available

  135. XU M, Wu X, Liu Z, Ding Y, et al
    A novel mouse model of diabetes, atherosclerosis and fatty liver disease using an AAV8-PCSK9-D377Y injection and dietary manipulation in db/db mice.
    Biochem Biophys Res Commun. 2022;622:163-169.
    PubMed     Abstract available

  136. GUO B, Xu X, Shao M, Yang X, et al
    UDP-glucose 6-dehydrogenase lessens sorafenib sensitivity via modulating unfolded protein response.
    Biochem Biophys Res Commun. 2022;613:207-213.
    PubMed     Abstract available

  137. XU Y, Denning KL, Lu Y
    PPARalpha agonist WY-14,643 induces the PLA2/COX-2/ACOX1 pathway to enhance peroxisomal lipid metabolism and ameliorate alcoholic fatty liver in mice.
    Biochem Biophys Res Commun. 2022;613:47-52.
    PubMed     Abstract available

  138. TOYOTA A, Goto M, Miyamoto M, Nagashima Y, et al
    Novel protein kinase cAMP-Activated Catalytic Subunit Alpha (PRKACA) inhibitor shows anti-tumor activity in a fibrolamellar hepatocellular carcinoma model.
    Biochem Biophys Res Commun. 2022;621:157-161.
    PubMed     Abstract available

    June 2022
  139. HONG W, Peng X, Zhou X, Li P, et al
    FXR/ASS1 axis attenuates the TAA-induced liver injury through arginine metabolism.
    Biochem Biophys Res Commun. 2022;611:31-37.
    PubMed     Abstract available

  140. MENG J, Zhang C, Wang D, Zhu L, et al
    Mitochondrial GCN5L1 regulates cytosolic redox state and hepatic gluconeogenesis via glycerol phosphate shuttle GPD2.
    Biochem Biophys Res Commun. 2022;621:1-7.
    PubMed     Abstract available

  141. GAO L, Zhang Y, Gao X, Xu L, et al
    Methylation of the HCBP6 promoter is associated with primary biliary cholangitis pathogenesis.
    Biochem Biophys Res Commun. 2022;610:176-181.
    PubMed     Abstract available

  142. KE X, Zhang R, Li P, Zuo L, et al
    Hydrochloride Berberine ameliorates alcohol-induced liver injury by regulating inflammation and lipid metabolism.
    Biochem Biophys Res Commun. 2022;610:49-55.
    PubMed     Abstract available

  143. JUNG SY, Yun HH, Lim JH, Lee DH, et al
    Hepatocyte-specific deletion of Bis causes senescence in the liver without deteriorating hepatic function.
    Biochem Biophys Res Commun. 2022;619:42-48.
    PubMed     Abstract available

  144. CAI Q, Zhu J, Cui X, Xia Y, et al
    S100A9 promotes inflammatory response in diabetic nonalcoholic fatty liver disease.
    Biochem Biophys Res Commun. 2022;618:127-132.
    PubMed     Abstract available

  145. LI S, Wang Y, Dun W, Han W, et al
    Phosphoproteomic analysis of FAC overload-triggered human hepatic cells reveals G2/M phase arrest.
    Biochem Biophys Res Commun. 2022;619:62-67.
    PubMed     Abstract available

  146. SAKURAI M, Weber P, Wolff G, Wieder A, et al
    TSC22D4 promotes TGFbeta1-induced activation of hepatic stellate cells.
    Biochem Biophys Res Commun. 2022;618:46-53.
    PubMed     Abstract available

  147. WU W, Lu P, Huang Y, Zhu Z, et al
    Emodin regulates the autophagy via the miR-371a-5p/PTEN axis to inhibit hepatic malignancy.
    Biochem Biophys Res Commun. 2022;619:1-8.
    PubMed     Abstract available

  148. FAN K, Zan X, Zhi Y, Yang Y, et al
    Immune response gene 1 deficiency impairs Nrf2 activation and aggravates liver fibrosis in mice.
    Biochem Biophys Res Commun. 2022;607:103-109.
    PubMed     Abstract available

  149. OH HA, Kim YJ, Moon KS, Seo JW, et al
    Identification of integrative hepatotoxicity induced by lysosomal phospholipase A2 inhibition of cationic amphiphilic drugs via metabolomics.
    Biochem Biophys Res Commun. 2022;607:1-8.
    PubMed     Abstract available

  150. HUANG L, He X, Peng W, He X, et al
    Hyperuricemia induces liver injury by upregulating HIF-1alpha and inhibiting arginine biosynthesis pathway in mouse liver and human L02 hepatocytes.
    Biochem Biophys Res Commun. 2022;617.
    PubMed     Abstract available

    May 2022
  151. MA Y, Li Q, Chen G, Tan Z, et al
    Transcriptomic analysis reveals a novel regulatory factor of ECHDC1 involved in lipid metabolism of non-alcoholic fatty liver disease.
    Biochem Biophys Res Commun. 2022;605:1-8.
    PubMed     Abstract available

  152. YOKOBORI K, Gruzdev A, Negishi M
    Mice blocking Ser347 phosphorylation of pregnane x receptor develop hepatic fasting-induced steatosis and hypertriglyceridemia.
    Biochem Biophys Res Commun. 2022;615:75-80.
    PubMed     Abstract available

  153. WEN H, He R, Wang H, Zhao S, et al
    Effects of small molecule inhibitor SW033291 on hepatic ischemia-reperfusion injury in mice.
    Biochem Biophys Res Commun. 2022;615:70-74.
    PubMed     Abstract available

  154. LI J, Huang L, Xiong W, Qian Y, et al
    Aerobic exercise improves non-alcoholic fatty liver disease by down-regulating the protein expression of the CNPY2-PERK pathway.
    Biochem Biophys Res Commun. 2022;603:35-40.
    PubMed     Abstract available

    April 2022
  155. LIU Q, Tang Q, Jing X, Zhang J, et al
    Mesencephalic astrocyte-derived neurotrophic factor protects against paracetamol -induced liver injury by inhibiting PERK-ATF4-CHOP signaling pathway.
    Biochem Biophys Res Commun. 2022;602:163-169.
    PubMed     Abstract available

  156. FUKUCHI T, Ueno T, Yamamoto T, Noguchi T, et al
    Liver progenitor cells may construct cysts having heterogeneous gene expression of liver-enriched transcription factors in mice with conditional knockout of the Hhex gene.
    Biochem Biophys Res Commun. 2022;602:49-56.
    PubMed     Abstract available

  157. ZHANG X, An T, Zhang X, Shen T, et al
    DDX17 protects hepatocytes against oleic acid/palmitic acid-induced lipid accumulation.
    Biochem Biophys Res Commun. 2022;612:169-175.
    PubMed     Abstract available

  158. LIAO C, Zhang L, Jiang R, Xu J, et al
    Inhibition of NAD kinase elevates the hepatic NAD(+) pool and alleviates acetaminophen-induced acute liver injury in mice.
    Biochem Biophys Res Commun. 2022;612:70-76.
    PubMed     Abstract available

  159. XIAO F, Xu F, Zhang H, Shuai X, et al
    Circ_0000591 served as endogenous RNA for miR-326 to promote progression of cholangiocarcinoma via the TLR4/MyD88/IL6 axis.
    Biochem Biophys Res Commun. 2022;600:101-108.
    PubMed     Abstract available

  160. WANG R, Ren Y, Bao T, Wang T, et al
    Inulin activates FXR-FGF15 signaling and further increases bile acids excretion in non-alcoholic fatty liver disease mice.
    Biochem Biophys Res Commun. 2022;600:156-162.
    PubMed     Abstract available

  161. EL-ASHMAWY NE, Khedr NF, Sallam M, Nossier AI, et al
    Effect of activation of liver X receptor alpha on cardiac & hepatic ABCC10 and SLC17A5 drug transporters in hypercholesterolemic rat model.
    Biochem Biophys Res Commun. 2022;610:133-139.
    PubMed     Abstract available

  162. XU ZX, Li JZ, Li Q, Xu MY, et al
    CircRNA608-microRNA222-PINK1 axis regulates the mitophagy of hepatic stellate cells in NASH related fibrosis.
    Biochem Biophys Res Commun. 2022;610:35-42.
    PubMed     Abstract available

  163. JUNG TW, Jeong JC, Park SY, Cho W, et al
    Abietic acid alleviates endoplasmic reticulum stress and lipid accumulation in human primary hepatocytes through the AMPK/ORP150 signaling.
    Biochem Biophys Res Commun. 2022;608:142-148.
    PubMed     Abstract available

  164. AI L, Wang Q, Cheng K
    Key genes in the liver fibrosis process are mined based on single-cell transcriptomics.
    Biochem Biophys Res Commun. 2022;598:131-137.
    PubMed     Abstract available

    March 2022
  165. FUNATO K, Otsuka M, Sekiba K, Miyakawa Y, et al
    Hepatitis B virus-associated hepatocellular carcinoma with Smc5/6 complex deficiency is susceptible to PARP inhibitors.
    Biochem Biophys Res Commun. 2022;607:89-95.
    PubMed     Abstract available

  166. YAN H, He N, He S
    HCG15 is a hypoxia-responsive lncRNA and facilitates hepatocellular carcinoma cell proliferation and invasion by enhancing ZNF641 transcription.
    Biochem Biophys Res Commun. 2022;608:170-176.
    PubMed     Abstract available

  167. NHO B, Ko KR, Kim S, Lee J, et al
    Intramuscular injection of a plasmid DNA vector expressing hepatocyte growth factor (HGF) ameliorated pain symptoms by controlling the expression of pro-inflammatory cytokines in the dorsal root ganglion.
    Biochem Biophys Res Commun. 2022;607:60-66.
    PubMed     Abstract available

  168. CHEN Z, Liu S, Xie P, Zhang B, et al
    Tumor-derived PD1 and PD-L1 could promote hepatocellular carcinoma growth through autophagy induction in vitro.
    Biochem Biophys Res Commun. 2022;605:82-89.
    PubMed     Abstract available

  169. SHU Z, Zhang G, Zhu X, Xiong W, et al
    Estrogen receptor alpha mediated M1/M2 macrophages polarization plays a critical role in NASH of female mice.
    Biochem Biophys Res Commun. 2022;596:63-70.
    PubMed     Abstract available

  170. CHEN R, Luo X, Jiang X, Deng S, et al
    Vinexin beta deficiency exacerbates diet-induced obesity, hepatosteatosis, insulin resistance and endoplasmic reticulum stress in mice.
    Biochem Biophys Res Commun. 2022;596:14-21.
    PubMed     Abstract available

  171. CHEN Q, Huang J, Tong W, Gui X, et al
    The geometry-dependent regulation of hepatic stellate cells by graphene oxide nanomaterials.
    Biochem Biophys Res Commun. 2022;604:179-184.
    PubMed     Abstract available

  172. ZHANG C, Lin J, Zhen C, Wang F, et al
    Amygdalin protects against acetaminophen-induced acute liver failure by reducing inflammatory response and inhibiting hepatocyte death.
    Biochem Biophys Res Commun. 2022;602:105-112.
    PubMed     Abstract available

    February 2022
  173. LI X, Yang M, Sun H, Ferdous MRU, et al
    Liver cyclophilin D deficiency inhibits the progression of early NASH by ameliorating steatosis and inflammation.
    Biochem Biophys Res Commun. 2022;594:168-176.
    PubMed     Abstract available

  174. SHI C, Pei M, Wang Y, Chen Q, et al
    Changes of flavin-containing monooxygenases and trimethylamine-N-oxide may be involved in the promotion of non-alcoholic fatty liver disease by intestinal microbiota metabolite trimethylamine.
    Biochem Biophys Res Commun. 2022;594:1-7.
    PubMed     Abstract available

  175. O G, Cascione S, Michielin F, Elvassore N, et al
    The emergence of the circadian clock network in hiPSC-derived hepatocytes on chip.
    Biochem Biophys Res Commun. 2022;601:109-115.
    PubMed     Abstract available

  176. YAMAGUCHI M, Ohbayashi S, Ooka A, Yamashita H, et al
    Harmine suppresses collagen production in hepatic stellate cells by inhibiting DYRK1B.
    Biochem Biophys Res Commun. 2022;600:136-141.
    PubMed     Abstract available

    January 2022
  177. QIAN M, Cao S, Wang T, Xu X, et al
    Apoptosis triggered by cytolethal distending toxin B subunit of Helicobacter hepaticus is aggravated by autophagy inhibition in mouse hepatocytes.
    Biochem Biophys Res Commun. 2022;598:40-46.
    PubMed     Abstract available

  178. KIMURA A, Kamimura K, Ohkoshi-Yamada M, Shinagawa-Kobayashi Y, et al
    Effects of a novel selective PPARalpha modulator, statin, sodium-glucose cotransporter 2 inhibitor, and combinatorial therapy on the liver and vasculature of medaka nonalcoholic steatohepatitis model.
    Biochem Biophys Res Commun. 2022;596:76-82.
    PubMed     Abstract available

  179. WANG M, Li B, Qin F, Ye J, et al
    Obesity induced Ext1 reduction mediates the occurrence of NAFLD.
    Biochem Biophys Res Commun. 2022;589:123-130.
    PubMed     Abstract available

  180. LEE N, Heo YJ, Choi SE, Jeon JY, et al
    Hepatoprotective effects of gemigliptin and empagliflozin in a murine model of diet-induced non-alcoholic fatty liver disease.
    Biochem Biophys Res Commun. 2022;588:154-160.
    PubMed     Abstract available

  181. KANDA Y, Ohata H, Miyazaki T, Sakai H, et al
    NF-kappaB suppression synergizes with E7386, an inhibitor of CBP/beta-catenin interaction, to block proliferation of patient-derived colon cancer spheroids.
    Biochem Biophys Res Commun. 2022;586:93-99.
    PubMed     Abstract available

    December 2021
  182. JUN H, ZeXin Z
    Screening of pyroptosis-related genes influencing the therapeutic effect of dehydroabietic acid in liver cancer and construction of a survival nomogram.
    Biochem Biophys Res Commun. 2021;585:103-110.
    PubMed     Abstract available

  183. CANG X, Wang Y, Zeng J, Gao J, et al
    C9orf72 knockdown alleviates hepatic insulin resistance by promoting lipophagy.
    Biochem Biophys Res Commun. 2021;588:15-22.
    PubMed     Abstract available

  184. LIU Z, Ma C, Wang Q, Yang H, et al
    Targeting FAM134B-mediated reticulophagy activates sorafenib-induced ferroptosis in hepatocellular carcinoma.
    Biochem Biophys Res Commun. 2021;589:247-253.
    PubMed     Abstract available

    November 2021
  185. SHI Y, Wei Q, Liu Y, Yuan J, et al
    The alleviating effect of sphingosine kinases 2 inhibitor K145 on nonalcoholic fatty liver.
    Biochem Biophys Res Commun. 2021;580:1-6.
    PubMed     Abstract available

  186. ZHANG WW, Xue R, Mi TY, Shen XM, et al
    Propofol ameliorates acute postoperative fatigue and promotes glucagon-regulated hepatic gluconeogenesis by activating CREB/PGC-1alpha and accelerating fatty acids beta-oxidation.
    Biochem Biophys Res Commun. 2021;586:121-128.
    PubMed     Abstract available

  187. SZTOLSZTENER K, Harasim-Symbor E, Chabowski A, Konstantynowicz-Nowicka K, et al
    The influence of dexamethasone on hepatic fatty acids metabolism and transport in human steatotic HepG2 cell line exposed to palmitate.
    Biochem Biophys Res Commun. 2021;585:132-138.
    PubMed     Abstract available

  188. LI Y, Dong J, Zhou Y, Ye X, et al
    Therapeutic effects of CXCL9-overexpressing human umbilical cord mesenchymal stem cells on liver fibrosis in rats.
    Biochem Biophys Res Commun. 2021;584:87-94.
    PubMed     Abstract available

    October 2021
  189. LIU H, Wang M, Jin Z, Sun D, et al
    FNDC5 induces M2 macrophage polarization and promotes hepatocellular carcinoma cell growth by affecting the PPARgamma/NF-kappaB/NLRP3 pathway.
    Biochem Biophys Res Commun. 2021;582:77-85.
    PubMed     Abstract available

  190. FANG J, Liang W
    ASCs -derived exosomes loaded with vitamin A and quercetin inhibit rapid senescence-like response after acute liver injury.
    Biochem Biophys Res Commun. 2021;572:125-130.
    PubMed     Abstract available

    September 2021
  191. CHO J, Tsugawa Y, Imai Y, Imai T, et al
    Chorionic gonadotropin stimulates maternal hepatocyte proliferation during pregnancy.
    Biochem Biophys Res Commun. 2021;579:110-115.
    PubMed     Abstract available

  192. XU L, Yang C, Wang J, Li Z, et al
    Persistent mTORC1 activation via Depdc5 deletion results in spontaneous hepatocellular carcinoma but does not exacerbate carcinogen- and high-fat diet-induced hepatic carcinogenesis in mice.
    Biochem Biophys Res Commun. 2021;578:142-149.
    PubMed     Abstract available

  193. JIN Y, Yang R, Ding J, Zhu F, et al
    KAT6A is associated with sorafenib resistance and contributes to progression of hepatocellular carcinoma by targeting YAP.
    Biochem Biophys Res Commun. 2021;585:185-190.
    PubMed     Abstract available

    August 2021
  194. HUANG T, Yu J, Luo Z, Yu L, et al
    Translatome analysis reveals the regulatory role of betaine in high fat diet (HFD)-induced hepatic steatosis.
    Biochem Biophys Res Commun. 2021;575:20-27.
    PubMed     Abstract available

  195. WANG Z, Qu K, Zhou L, Ren L, et al
    Apaf1 nanoLuc biosensors identified lentinan as a potent synergizer of cisplatin in targeting hepatocellular carcinoma cells.
    Biochem Biophys Res Commun. 2021;577:45-51.
    PubMed     Abstract available

  196. CHEN B, Cha JH, Yan M, Cao N, et al
    ATXN7L3B promotes hepatocellular carcinoma stemness and is downregulated by metformin.
    Biochem Biophys Res Commun. 2021;573:1-8.
    PubMed     Abstract available

    July 2021
  197. KIM H, Lee JY, Park SJ, Kwag E, et al
    ZNF746/PARIS promotes the occurrence of hepatocellular carcinoma.
    Biochem Biophys Res Commun. 2021;563:98-104.
    PubMed     Abstract available

  198. LIU P, Xia P, Fu Q, Liu C, et al
    miR-199a-5p inhibits the proliferation of hepatocellular carcinoma cells by regulating CDC25A to induce cell cycle arrest.
    Biochem Biophys Res Commun. 2021;571:96-103.
    PubMed     Abstract available

  199. LEILEI L, Xue S, Yan L, Yuyuan L, et al
    PM2.5-exposed hepatocytes induce hepatic stellate cells activation by releasing TGF-beta1.
    Biochem Biophys Res Commun. 2021;569:125-131.
    PubMed     Abstract available

    June 2021
  200. HE Y, Pei JH, Li XQ, Chi G, et al
    IL-35 promotes EMT through STAT3 activation and induces MET by promoting M2 macrophage polarization in HCC.
    Biochem Biophys Res Commun. 2021;559:35-41.
    PubMed     Abstract available

  201. YU HM, Chung HK, Park KS
    The PDE5 inhibitor udenafil ameliorates nonalcoholic fatty liver disease by improving mitochondrial function.
    Biochem Biophys Res Commun. 2021;558:57-63.
    PubMed     Abstract available

  202. LIU C, Huang XY, Huang Y
    FAM83G promotes proliferation, invasion, and metastasis by regulating PI3K/AKT signaling in hepatocellular carcinoma cells.
    Biochem Biophys Res Commun. 2021;567:63-71.
    PubMed     Abstract available

  203. OUYANG X, Yao L, Liu G, Liu S, et al
    Loss of androgen receptor promotes HCC invasion and metastasis via activating circ-LNPEP/miR-532-3p/RAB9A signal under hypoxia.
    Biochem Biophys Res Commun. 2021;557:26-32.
    PubMed     Abstract available

  204. LI Y, Yi Q, Liao X, Han C, et al
    Hypomethylation-driven overexpression of HJURP promotes progression of hepatocellular carcinoma and is associated with poor prognosis.
    Biochem Biophys Res Commun. 2021;566:67-74.
    PubMed     Abstract available

  205. MA Y, Sun W, Zhang Q, Gao B, et al
    lncRNA BSG-AS1 is hypoxia-responsive and promotes hepatocellular carcinoma by enhancing BSG mRNA stability.
    Biochem Biophys Res Commun. 2021;566:101-107.
    PubMed     Abstract available

  206. ZENG Z, Shi Z, Liu Y, Zhao J, et al
    HIF-1alpha-activated TM4SF1-AS1 promotes the proliferation, migration, and invasion of hepatocellular carcinoma cells by enhancing TM4SF1 expression.
    Biochem Biophys Res Commun. 2021;566:80-86.
    PubMed     Abstract available

  207. SATO T, Tsuchiya A, Owaki T, Kumagai M, et al
    Severe steatosis and mild colitis are important for the early occurrence of hepatocellular carcinoma.
    Biochem Biophys Res Commun. 2021;566:36-44.
    PubMed     Abstract available

    May 2021
  208. WANG Y, Yang H, Zhang G, Luo C, et al
    hsa-miR-7-5p suppresses proliferation, migration and promotes apoptosis in hepatocellular carcinoma cell lines by inhibiting SPC24 expression.
    Biochem Biophys Res Commun. 2021;561:80-87.
    PubMed     Abstract available

  209. YUAN Y, Yuan HF, Geng Y, Zhao LN, et al
    Aspirin modulates 2-hydroxyisobutyrylation of ENO1K281 to attenuate the glycolysis and proliferation of hepatoma cells.
    Biochem Biophys Res Commun. 2021;560:172-178.
    PubMed     Abstract available

  210. PHO-IAM T, Punnakitikashem P, Somboonyosdech C, Sripinitchai S, et al
    PLGA nanoparticles containing alpha-fetoprotein siRNA induce apoptosis and enhance the cytotoxic effects of doxorubicin in human liver cancer cell line.
    Biochem Biophys Res Commun. 2021;553:191-197.
    PubMed     Abstract available

  211. GOTO N, Shibutani S, Miura N, Watanabe R, et al
    Thapsigargin suppresses alpha 1-acid glycoprotein secretion independently of N-glycosylation and ER stress.
    Biochem Biophys Res Commun. 2021;552:30-36.
    PubMed     Abstract available

  212. ZHANG Q, Yang M, Qu Z, Zhou J, et al
    Corrigendum to Autophagy prevention sensitizes AKTi-1/2-induced anti-hepatocellular carcinoma cell activity in vitro and in vivo" [Biochem. Biophys. Res. Commun. (2016) 480(3) 334-340].
    Biochem Biophys Res Commun. 2021 May 5. pii: S0006-291X(21)00735.

  213. YANG X, Yao B, Niu Y, Chen T, et al
    Corrigendum to hypoxia-induced lncRNA EIF3J-AS1 accelerates hepatocellular carcinoma progression via targeting miR-122-5p/CTNND2 axis.
    Biochem Biophys Res Commun. 2021 May 5. pii: S0006-291X(21)00729.

    April 2021
  214. OHYA K, Imamura M, Teraoka Y, Uchida T, et al
    Novel drug resistance-associated substitutions against pibrentasvir emerged in genotype 1b hepatitis C virus-infected human hepatocyte transplanted mice.
    Biochem Biophys Res Commun. 2021;559:78-83.
    PubMed     Abstract available

  215. YAN L, Zhang X, Fu J, Liu Q, et al
    Inhibition of the transient receptor potential vanilloid 3 channel attenuates carbon tetrachloride-induced hepatic fibrosis.
    Biochem Biophys Res Commun. 2021;558:86-93.
    PubMed     Abstract available

  216. ZHANG H, Yao W, Zhang M, Lu Y, et al
    TTK inhibitor promotes radiosensitivity of liver cancer cells through p21.
    Biochem Biophys Res Commun. 2021;550:84-91.
    PubMed     Abstract available

  217. WANG TT, Hong YF, Chen ZH, Wu DH, et al
    Synergistic effects of alpha-Mangostin and sorafenib in hepatocellular carcinoma: New insights into alpha-mangostin cytotoxicity.
    Biochem Biophys Res Commun. 2021;558:14-21.
    PubMed     Abstract available

  218. KATO T, Murata D, Anders RA, Sesaki H, et al
    Nuclear PTEN and p53 suppress stress-induced liver cancer through distinct mechanisms.
    Biochem Biophys Res Commun. 2021;549:83-90.
    PubMed     Abstract available

  219. YOSHINO K, Hosooka T, Shinohara M, Aoki C, et al
    Canagliflozin ameliorates hepatic fat deposition in obese diabetic mice: Role of prostaglandin E2.
    Biochem Biophys Res Commun. 2021;557:62-68.
    PubMed     Abstract available

  220. LI G, Du P, He J, Li Y, et al
    CircRNA circBACH1 (hsa_circ_0061395) serves as a miR-656-3p sponge to facilitate hepatocellular carcinoma progression through increasing SERBP1 expression.
    Biochem Biophys Res Commun. 2021;556:1-8.
    PubMed     Abstract available

  221. WU M, Chen P, Liu F, Lv B, et al
    ONX0912, a selective oral proteasome inhibitor, triggering mitochondrial apoptosis and mitophagy in liver cancer.
    Biochem Biophys Res Commun. 2021;547:102-110.
    PubMed     Abstract available

  222. LI D, Xie P, Zhao S, Zhao J, et al
    Hepatocytes derived increased SAA1 promotes intrahepatic platelet aggregation and aggravates liver inflammation in NAFLD.
    Biochem Biophys Res Commun. 2021;555:54-60.
    PubMed     Abstract available

    March 2021
  223. FAN Z, Gao Y, Zhang W, Yang G, et al
    METTL3/IGF2BP1/CD47 contributes to the sublethal heat treatment induced mesenchymal transition in HCC.
    Biochem Biophys Res Commun. 2021;546:169-177.
    PubMed     Abstract available

  224. PARK NY, Jo DS, Park SJ, Lee H, et al
    Depletion of HNRNPA1 induces peroxisomal autophagy by regulating PEX1 expression.
    Biochem Biophys Res Commun. 2021;545:69-74.
    PubMed     Abstract available

  225. XIN Y, Xu L, Zhang X, Yang C, et al
    Sirtuin 6 ameliorates alcohol-induced liver injury by reducing endoplasmic reticulum stress in mice.
    Biochem Biophys Res Commun. 2021;544:44-51.
    PubMed     Abstract available

    February 2021
  226. ZHANG Y, Sun Y, Zhang Y, Miao Q, et al
    Nuclear factor Y participates in alcoholic liver disease by activating SREBP1 expression in mice.
    Biochem Biophys Res Commun. 2021;541:90-94.
    PubMed     Abstract available

  227. YANG M, Cui Y, Song J, Cui C, et al
    Mesenchymal stem cell-conditioned medium improved mitochondrial function and alleviated inflammation and apoptosis in non-alcoholic fatty liver disease by regulating SIRT1.
    Biochem Biophys Res Commun. 2021;546:74-82.
    PubMed     Abstract available

    January 2021
  228. XIAO T, Cui Y, Ji H, Yan L, et al
    Baicalein attenuates acute liver injury by blocking NLRP3 inflammasome.
    Biochem Biophys Res Commun. 2021;534:212-218.
    PubMed     Abstract available

  229. LI Y, Xia J, Shao F, Zhou Y, et al
    Sorafenib induces mitochondrial dysfunction and exhibits synergistic effect with cysteine depletion by promoting HCC cells ferroptosis.
    Biochem Biophys Res Commun. 2021;534:877-884.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.